‘Fantastic’ bonds kick Roche loan into touch

Roche’s plans for a jumbo loan have been thrown into doubt after the Swiss drugs group issued more than $14bn of bonds in Europe this week, adding to the $16bn trade it made last week in the US. The bonds mean Roche has little need to tap the bank market to fund its $42bn hostile bid for Genentech.

  • 26 Feb 2009

The borrower has said that as well as using cash to fund its $86.50 a share offer, it might also issue CP.

“I have absolutely no idea if there will be a loan anymore,” said a banker from an institution set to be one of the lead banks on ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Citi 3,237 10 19.12
2 Goldman Sachs 2,096 5 12.39
3 Morgan Stanley 1,965 5 11.61
4 BNP Paribas 1,686 6 9.96
5 Barclays 1,565 4 9.25

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 30,859.27 98 11.55%
2 JPMorgan 25,235.99 70 9.44%
3 Wells Fargo Securities 24,432.24 66 9.14%
4 Bank of America Merrill Lynch 23,023.30 73 8.61%
5 Barclays 16,351.18 54 6.12%